Bradycardic arrhythmias
Jung, W.; Manz, M.; Lüderitz, B.
Der Internist 33(6): W57-W68
1992
ISSN/ISBN: 0020-9554 PMID: 1628922 Document Number: 394998
Document emailed within 1 workday
Related Documents
Chichkanov, G.G.; Tsorin, I.B.; Kirsanova, G.Iu.; Berdiaev, S.Iu.; Khorunzhił, V.A. 1997: Derivatives of 2-mercaptobenzimidazole--a new group of specific bradycardic drugs Eksperimental'naia i Klinicheskaia Farmakologiia 60(3): 23-26Schmitz-Spanke, S.; Granetzny, A.; Stoffels, B.; Pomblum, V.J.; Gams, E.; Schipke, J.D. 2004: Effects of a bradycardic agent on postischemic cardiac recovery in rabbits Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 55(4): 705-712
Hebbar, A.K.; Hueston, W.J. 2002: Management of common arrhythmias: Part I. Supraventricular arrhythmias American Family Physician 65(12): 2479-2486
Chichkanov, G.G.; Tsorin, I.B.; Kirsanova, G.I. 1998: The anti-ischemic properties of new specific bradycardic agents, derivatives of 2-mercaptobenzimidazole Eksperimental'naia i Klinicheskaia Farmakologiia 61(6): 20-24
Chichkanov, G.G.; Tsorin, I.B.; Kirsanova, G.I.; Berdiaev, S.I.; Turilova, A.I. 1997: Anti-arrhythmic properties of specific bradycardic agents from the group of 2-mercaptobenzimidazole derivatives Eksperimental'naia i Klinicheskaia Farmakologiia 60(5): 35-39
Diewitz, M. 1974: Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias Medizinische Klinik 69(18): 806-813
Gross, G.J.; Daemmgen, J.W. 1986: Beneficial effects of two specific bradycardic agents AQ-A39 (falipamil) and AQ-AH 208 on reversible myocardial reperfusion damage in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 238(2): 422-428
Safonova, E.V.; Zharova, E.A.; Samoĭlenko, L.E.; Sergienko, V.B. 2003: Preliminary data on combined assessment of tolerance to exercise, left ventricular contractile function in ischemic heart disease patients taking bradycardic agents Terapevticheskii Arkhiv 75(4): 29-33
Gout, B.; Jean, J.; Bril, A. 1992: Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function Journal of Pharmacology and Experimental Therapeutics 262(3): 987-994
Deegen, E. 1976: Diagnosis and significance of arrhythmias in the horse. II. Clinical significance of arrhythmias Deutsche Tierärztliche Wochenschrift 83(11): 483-489
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Jurkovicová, O.; Cagán, S. 1998: Reperfusion arrhythmias Bratislavske Lekarske Listy 99(3-4): 162-171
Rials, S.J.; Marinchak, R.A.; Kowey, P.R. 1992: Arrhythmias in the elderly Cardiovascular Clinics 22(2): 139-157
Spang, K. 1971: Prevention of serious arrhythmias Die Medizinische Welt 14: 539-542
Iakhontova, O.I.; Valenkevich, L.N.; Rutgaĭzer, I.M. 1998: Cardiac arrhythmias Klinicheskaia Meditsina 76(7): 50-55
Rothlin, M. 1973: Treatment of arrhythmias Schweizerische Rundschau für Medizin Praxis 62(8): 210-214
Bastaroli, J.C.; Castagnino, H.E. 1972: Lidocaine and arrhythmias Medicina 32(2): 168-182
Bisht, D.B.; Banerji, K. 1972: LB-46 in cardiac arrhythmias Indian Heart Journal 24(Suppl 1): 205-210
Cooper, D. 1979: Cardiac arrhythmias British Journal of Hospital Medicine 22(1): 104
Brownlee, W.T. 1985: Acute arrhythmias British Journal of Hospital Medicine 33(3): 138-145